WHO declares monkeypox a public health emergency of international concern (PHEIC) 7/23/22 HHS extends COVID-19 public health emergency again 7/15/22 FDA authorizes Novavax protein subunit COVID-19 vaccine for those 18 and older 7/13/22 FDA recommends repeat dosing for Evusheld every six months 6/29/22 FDA extends Evusheld shelf life from 18 to 24 months 6/28/22 FDA expands authorization of Pfizer/BioNTech and Moderna vaccines to those ages 6 months to 4 years old 6/17/22 CDC recommended Pfizer COVID-19 vaccine booster shots for those ages 5-11 5/19/22 FDA authorizes mail-in, non-prescription test for influenza, SARS-CoV-2, and RSV 5/16/22 Safety and efficacy of SARS-CoV-2 vaccination in the immunocompromised 5/12/22 FDA Q&A provides information on Paxlovid 5/4/22 COVID-19 Public Health Emergency renewed for 90 days 4/12/22 Sotrovimab no longer authorized in U.S. due to rise of Omicron sub-variant BA.2 4/5/22 ASPR launches COVID-19 Test to Treat locator tool 3/31/22 Researchers announce use of COVID-19 vaccine to treat chronic SARS-CoV-2 infection 3/21/22 Congress extends pandemic telehealth flexibilities in FY 2022 spending bill 3/15/22 CDC announces new metrics for gauging COVID-19 risk and guiding mitigation strategies like masking 2/25/22 FDA doubles recommended dose of Evusheld for COVID-19 prevention 2/24/22 Federal government purchases additional doses of COVID-19 preventative Evusheld 2/14/22 FDA authorizes monoclonal antibody bebtelovimab for treatment of COVID-19 in high-risk patients 2/11/22 CDC recommends COVID-19 booster three months from primary mRNA vaccine series for immunocompromised 2/11/22 FDA amends authorizations for an additional COVID-19 mRNA vaccine dose for immunocompromised 8/13/21
